News

09/30/2020 to 10/03/2020 - Bone Solutions, Inc. will be attending the Orthopaedic Trauma Association (OTA) Annual Meeting in Nashville, TN.
02/25/2020 - Bone Solutions, Inc. reaches 1000 implants of its proprietary magnesium-based bone void filler.
08/28/2019 - Bone Solutions Inc., announces a private label licensing agreement with Onkos Surgical.
08/19/2019 - Bone Solutions Inc., announces a private label licensing agreement with WishBone Medical.
03/12/2019 to 03/16/2019 - Bone Solutions, Inc. will be attending the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting March 7-9 2018, in Las Vegas, NV. Please look for us at Booth 2567.
02/26/2019 - Bone Solutions, Inc. reaches 500 implants of its proprietary magnesium-based bone void filler.
03/07/2018 to 03/09/2018 - Bone Solutions, Inc. will be attending the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting March 7-9 2018, in New Orleans, LA. Please look for us at Booth 1714.
09/28/2017 - Bone Solutions Inc. announces 1st implantation of OsteoCrete® Magnesium-based bone void filler.

QUALITY STATEMENT

Bone Solutions is committed to provide quality medical devices to the global medical device marketplace that improve patient care, meet regulatory and customer requirements, while assuring the continual effectiveness and improvement of Bone Solutions’ Quality System.

ABOUT US

Bone Solutions Inc. is dedicated to improving patients’ lives through superior magnesium biologic implant solutions. Our magnesium biologic implants are biologically safe, fully resorbable and have similar mechanical properties of human bone.

This means they will eliminate the need for surgical revisions, minimize orthopedic stress fractures, and reduce the side effects of other non-degradable/resorbable or biologically inert implants. Headquartered in Colleyville, Texas, Bone Solutions Inc. is proud to develop, manufacture and distribute their products to allow surgeons to meet the orthopedic needs of our patients every day.

PRODUCTS

Resources

RESEARCH PAPERS

*All studies summaries are available upon request through customer service.

Bertone A_et al - Influence of bone cements on bone-screw interfaces in the third metacarpal and third metatarsal bones of horses
Bertone A_et al - Effects of Magnesium Adhesive Cement on Bone Stability and healing following a metatarsal osteotomy in horses
NAMSA – Bone Implantation Study, Rabbit Model – OsteoCrete® Bone Void Filler
Iannotti J_et al - Bone Graft Substitute Provides Metaphyseal Fixation for a Stemless Humeral Implant
Rodeo S_et al - Augmentation of Tendon-to-Bone Healing with a Magnesium-based Bone Adhesive
Roller B_et al - AJO - Use of a Novel Magnesium-Based Resorbable Bone Cement for Augmenting Anchor and Tendon Fixation.
Schendel S_et al - Magnesium-Based Bone Cement and Bone Void Filler Preliminary Experimental Studies

SYMBOLS GLOSSARY

BSI-SYMBOLS

Leadership

Drew M. Diaz – CEO

Over 30 years of experience working in leadership positions in healthcare and the medical device arena
Cofounded a US based medical device company
Held senior roles in medical device companies domestically and internationally
Has lived and worked in four different countries during his life and career
Managed offices in Brazil, Germany, India, China, and the United States

Brandon Roller MD, PhD – CTO

Medical Doctorate -University of Missouri-Columbia
Resident - Wake Forest Baptist Medical Center
Arthrex® Product Development (former)

Frankie L Morris – DIRECTOR OF ENGINEERING AND OPERATIONS

Over 15 years of medical device engineering, life cycle management, patent research, and portfolio development.
Experience managing marketing, quality, and regulatory initiatives on Class I and Class II devices.

Clinical Advisors

JOSEPH P. IANNOTTI, MD

Chief of Staff for Cleveland Clinic Florida Region
Chairman of the Orthropaedic and Rheumatology Institute at the Cleveland Clinic
Professor of Orthopaedic Surgery at University of Pennsylvania (former)

NED AMENDOLA, MD

Chief Medical Officer at Duke Health System
Director and Member of Integrative Performance Excellence Group at Duke University

BRANDON ROLLER, MD, PHD

Medical Doctorate -University of Missouri-Columbia
Resident - Wake Forest Baptist Medical Center
Arthrex® Product Development (former)

FRANCIS HORNICEK, MD, PHD

Professor and Chair, Department of Orthopedic Surgery UCLA Medical Center, Santa Monica
Former Chief of the Orthopedic Oncology Service at Massachusetts General Hospital (MGH)
Professor of Orthopedic Surgery at Harvard Medical School
Director MGH Stephan L. Harris Chordoma Center

STEPHEN SCHENDEL, MD

Professor of Surgery Emeritus at Stanford University Medical Center
Director of the California Craniofacial Institute

GARY PERLMUTTER, MD

Orthopedic Shoulder Surgeon, Massachusetts General Hospital
Clinical Instructor, Orthopedic Surgery, Harvard Medical School

BOARD OF DIRECTORS

Wade Hampton - Chairman / Board Member
Anthony Copp - Vice Chairman and Co-Founder / Board Member
Tom Lally - Co-Founder / Board Member
Drew Diaz - President and CEO / Board Member
Phil Holcomb - Board Member
Kevin Morano - Board Member
David J. Illingworth - Board Member
Cecil H. Rorabeck, OC, MD, FRCSC - Board Member
Robert Lutz - Board Member

Careers

Currently, there are no openings available.

DISTRIBUTORSHIPS

BSI is actively seeking highly motivated distributors. We value our distributors and view distributors as strategic partners.

For more information on becoming a distributor please contact us today.

Company Policy/Procedural Compliance
At Bone Solutions Inc., we are committed to complying with regulations and to meeting customer needs. We do this by maintaining the effectiveness of the Quality management system, periodically reviewing our objectives and instilling risk management principles throughout the product development lifecycle. Bone Solutions Inc. also follows all company policies and procedures as well as local, state and federal laws concerning employment to include, but not limited to: I-9 information, EEOC, Civil Rights and ADA. Bone Solutions Inc. is registered with the FDA and our Quality Management System is aligned to ensure consistent design, development, production, and delivery of medical devices that are safe for their intended function and purpose while operating within the framework of all applicable regulatory requirements.